Key facts
- TrueMed’s last known valuation is $158.5M (Mar 2025).
- It has raised $44.0M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($34.0M) in Mar 2025.
- Notable investors include Bessemer Venture Partners, M2O, Granite Point Partners, Highland Creek Partners, Learn Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for TrueMed
Funding rounds
1 roundsAbout TrueMed
Developer of a healthcare platform designed to enable consumers to use pre-tax HSA/FSA funds for proactive health and wellness purchases. The company's platform offers a qualification process for obtaining a letter of medical necessity for purchasing fitness equipment and supplements, enabling health-conscious individuals to enhance their health and well-being efficiently.
- Industry
- Specialty Retail
- Sector
- Consumer Products and Services (B2C)
- HQ
- Austin, TX, United States
- Founded
- 2022
- Employees
- 3
- Website
- truemed.com/
- Ownership
- Privately Held (backing)
TrueMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TrueMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TrueMed in its N-PORT filings yet. We sweep new filings monthly.